Dianthus Therapeutics, Inc. (DNTH)
NCM – Real Time Price. Currency in USD
110.16
+1.67 (1.54%)
Market open: Aug 12, 2026, 12:14 PM EDT
107.62
-0.87 (-0.80%)
Previous after-hours: Aug 11, 2026, 7:52 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
110.16
+1.67 (1.54%)
Market open: Aug 12, 2026, 12:14 PM EDT
107.62
-0.87 (-0.80%)
Previous after-hours: Aug 11, 2026, 7:52 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $110.5M significantly exceed its total debt $1.3M, ensuring strong financial flexibility
Total current assets $897.5M exceed Total current liabilities $34.4M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$49.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 26.10 | 6.05 | 10 | |
| Quick ratio | 26.10 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 6M | 3M | 6M | 2M | 2M |
| Gross Profit | 6M | 2M | 6M | 2M | 2M |
| Operating Income | -30M | -48M | -102M | -178M | -218M |
| Net Income | -28M | -44M | -85M | -162M | -192M |
| EBITDA | -30M | -48M | -101M | -178M | -217M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 1.22 | -1.76 | 2.0 |
| Next quarter | 38.82 | 24.28 | 10 |
| Current year | -12.78 | 9.4 | 3.5 |
| Next year | 14.65 | -21.6 | 4.5 |
| Weighted average score | 5.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 64.36 | -22.96 | -5.87 | -70.3 | 3.3 |
| Y/Y | 294.3 | -58.75 | -2.26 | -105.36 | 3.3 |
| 3y average | -0.88 | -79.67 | 19.6 | -67.8 | 3.0 |
| 5y average | 399.07 | -34.79 | 19 | -29.16 | 5.3 |
| Weighted average score | 3.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |